Latest Industry Insights

In this article, learn how semiconductor manufacturer STMicroelectronics is using advanced HPC technologies to help its customers and partners explore the world of next-generation wireless.

BYOD has become an essential cornerstone of modern clinical trials. This article discusses the adoption of BYOD and the benefits it can bring to patients.

In this interview with Zach Powers, CISO at Benchling, an R&D cloud platform for the biotechnology industry, we discuss why biotech is being targeted by cybercriminals, the importance of data security and how the industry can mitigate cyber threats.

Chris Sigley highlights some of the main findings from the Ethical Medicines Industry Group and Arkivum’s annual survey tracking the progress of digital transformation and clinical data strategies of 305 global life sciences organizations.

To understand how machine learning methods and new software capabilities are helping proteomics researchers gain greater depth in their analyses, Technology Networks recently interviewed Tharan Srikumar, product manager in bioinformatics at Bruker Daltonics.

This article explores the current state of brain-computer interface technology and some of the ethical considerations associated with its use.

In a recent interview with Technology Networks, Mathew Keegan discusses how automation is already enhancing the lab experience, the challenges it faces and where it may head in the future.

To learn more about new technologies being developed for drug discovery and cell therapy, Technology Networks spoke to bit.bio's Dr. Farah Patell-Socha and Furqan Iqbal.

Frank Pun discusses how scientists from Insilico Medicine identified numerous unreported potential therapeutic targets of amyotrophic lateral sclerosis using the company’s proprietary AI-enabled biological target discovery platform.

In this interview, we spoke to Rachel Marty Pyke PhD, manager of bioinformatics science at Personalis, to find out how machine learning can be used to detect genomic instability as a biomarker for cancer immunotherapy.